When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust into the limelight during the COVID-19 pandemic, but had been in ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the vital role MRNA technology played in COVID-19 vaccines.

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on ...

For decades prior to the pandemic, dedicated scientists pored over mRNA, learning how this class of molecules works in the body and how it might be leveraged to heal the sick and guard against disease ...

mRNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of huge federal funding cuts. When you purchase through links on our site, we ...

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. Cancer: it’s a diagnosis that most of us have learned to fear. On the one hand decades ...

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...